“HEATPAC” - a phase II randomized study of concurrent thermochemoradiotherapy versus chemoradiotherapy alone in locally advanced pancreatic cancer

BACKGROUND: Pancreatic cancer has a dismal prognosis with 5-year overall survival rate of around 5%. Although surgery is still the best option in operable cases, majority of the patients who present in locally advanced stages are deemed inoperable. Novel approaches are therefore needed for the manag...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Radiat Oncol
Glavni autori: Datta, Niloy Ranjan, Pestalozzi, Bernhard, Clavien, Pierre-Alain, Siebenhüner, Alexander, Puric, Emsad, Khan, Shaka, Mamot, Christoph, Riesterer, Oliver, Knuchel, Jürg, Reiner, Cäcilia Sophie, Bodis, Stephan
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Study Protocol
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5698973/
https://ncbi.nlm.nih.gov/pubmed/29162142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-017-0923-8
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items